Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 7 January 2025
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Press Release, 10 October 2024
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Press Release, 8 August 2024
Kuros Biosciences Reports First Half of 2024 Results
Press Release, 24 April 2024
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Press Release, 13 March 2024
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Press Release, 27 December 2023
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
adhoc-press-releases-media-investors